White Paper

Objectives And Considerations In Developing An Integrated Summary Of Efficacy (ISE)

Source: Rho

By Ben Vaughn

A new drug application (NDA) covers information about a product from inception through clinical trials. The integrated summary of efficacy (ISE) is a section of the NDA that provides a focused summary of efficacy data primarily from the pivotal phase 3 trials. This article discusses the primary goals and considerations for developing an ISE.